View item

US Department of Defense – Neurofibromatosis Research Program (NFRP) – New Investigator Award
Sponsor: US Department of Defense 		Closing Date: 26-Jul-2018
The Neurofibromatosis Research Program seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in neurofibromatosis (NF) research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; promote translational and clinical studies to move promising ideas from bench to bedside; and develop a balanced portfolio of meritorious research related to all aspects of NF type 1 (NF1) and type 2 (NF2), and schwannomatosis. The FY18 NFRP strongly encourages research applications that specifically address the critical needs of the NF community in one or more of the Areas of Emphasis.

The intent of the NFRP New Investigator Award is to support the continued development of promising independent investigators and/or the transition of established investigators from other research fields into a career in the field of NF research.

Eligibility
• Must be either:
- An independent investigator at or below the level of Assistant Professor (or equivalent) and must plan to commit at least 30% of his/her effort toward the proposed research project;
or
- An established independent investigator in an area other than NF at or above the level of Assistant Professor seeking to transition into a career in NF research and must plan to commit at least 10% of his/her effort toward the proposed research project.
• To be eligible, applicants may not have received more than $300,000 in direct costs for NF research as a PI of one or more Federally funded, non-mentored peer reviewed grants.

Key Mechanism Elements
• Prior experience in NF research is not required.
• Preliminary and/or published data relevant to NF and the proposed research project is required.
• Research projects may focus on any phase of research; however clinical trials are not allowed.

Funding
• Maximum funding of USD $450,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.

Please see the U.S. Department of Defense Congressionally Directed Medical Research Program (CDMRP) website at http://cdmrp.army.mil/funding/nfrp and http://cdmrp.army.mil/nfrp/default for further information. Pre-applications are submitted via the CDMRP’s Electronic Biomedical Research Application Portal (EBRAP) and full applications are submitted via Grants.gov. For complete instructions for pre-applications and full applications, you must refer to both the Program Announcement and General Application Instructions documents.

Key Dates
Full applications due to UQR&I: 19 July 2018
Pre-applications (mandatory) close with US Department of Defense: 26 July 2018
Full applications close with US Department of Defense: 9 August 2018

Ahead of internal review, ensure all online components on EBRAP or Grants.gov are complete. To initiate review, email your completed Funding Application Coversheet to internationalgrants@research.uq.edu.au. Interested applicants are strongly encouraged to make contact with the UQR&I international team (via internationalgrants@research.uq.edu.au) well in advance of the UQR&I internal deadline to discuss their application.
Website: http://cdmrp.army.mil/funding/nfrp

Return